A Phase 2, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Evaluate the Clinical Effect, Pharmacodynamic, Pha

A Phase 2, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Evaluate the Clinical Effect, Pharmacodynamic, Pharmacokinetic and Safety Profile of PF-06823859 in Adult Participants With Active CLE or SLE With Cutaneous Manifestations

Abierta

Código protocolo: C0251013
Código EudraCT: 2023-503343-33
Grupo de investigación: Reumatología
Servicio: Reumatología
Investigador/a principal: Cortes Hernandez, Josefina
Patología: Símptomes, signes i troballes anormals clíniques i de laboratori, no classificades enlloc més
Fase: Fase II